Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly

This article was originally published in The Gray Sheet

Executive Summary

Offering $150 mil. of 5.5% Euronotes maturing July 8, 1998. The notes are being offered in $1,000, $10,000 and $100,000 denominations at an issue price of 1.01369 times the value of the note. Interest will be paid annually. Payment for the notes is due July 8. The firm says the offering is part of a strategy to transfer short term floating rate debt into fixed rate medium and long term debt. Morgan Stanley International is lead manager for the offering.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000783

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel